JPMorgan Downgrades AstraZeneca (AZN) to Underweight
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Price: $51.56 -0.52%
Rating Summary:
2 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
2 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade AZN Now!
JPMorgan downgraded AstraZeneca (NYSE: AZN) from Neutral to Underweight.
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $47.28 yesterday, with a 52 week range of $39.72-$49.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $47.28 yesterday, with a 52 week range of $39.72-$49.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- Deutsche Bank Downgrades TRW Automotive Holdings (TRW) to Hold
- SunTrust Robinson Humphrey Downgrades Stryker (SYK) to Reduce
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
